When inhibitors develop, the standard treatments for conditions like hemophilia become less effective or completely ineffective. This can lead to increased bleeding episodes, joint damage, and a higher risk of complications. Nurses need to be adept at recognizing signs of inhibitor development, such as increased bleeding despite treatment, and communicating these observations to the healthcare team.
